Transdermal Drug Delivery Systems Market 2022-2027 Research Report: Featuring 3M, Viatris, Lavipharm, Luye Pharma Group and Others

December 13 19:18 2022
Transdermal Drug Delivery Systems Market 2022-2027 Research Report: Featuring 3M, Viatris, Lavipharm, Luye Pharma Group and Others
Transdermal Drug Delivery Systems Market Research Report 2022-2027
The global transdermal drug delivery systems market is primarily driven by the increasing preference for self-administered modes of drug delivery.

According to the latest report by IMARC Group, titled “Transdermal Drug Delivery Systems Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.36% during 2022-2027.

Year considered to estimate the market size:

• Base year of the analysis: 2021

• Historical period: 2016-2021

• Forecast period: 2022-2027

Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.

Request to get the sample report:

Market Insight:

Transdermal drug delivery systems involve a painless method of delivering drugs through the skin systematically. It is a preferred non-invasive alternative to the parenteral route and oral intravascular mode of drug delivery into the body. This method involves the penetration of drugs via the stratum corneum, which passes through the epidermis and dermis without the accumulation of drugs into the dermal layer of the skin. It is widely utilized for the treatment of chronic and acute illnesses as well as cosmetic therapies.

Transdermal Drug Delivery Systems Market Trends and Growth Drivers:

The global market is primarily driven by significant growth in the healthcare sector. Moreover, continual technological advancements across the industry, such as the introduction of iontophoresis that facilitates self-administration of drugs, are creating a positive outlook for the market. The rising investments by public and private firms to upgrade the existing healthcare infrastructure are also contributing to the market growth. Other factors, including the increasing preference for non-invasive treatments among the masses and extensive research and development (R&D) activities, are propelling the market growth further. 

Transdermal Drug Delivery Systems Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global transdermal drug delivery systems market has been studied in the report with the detailed profiles of the key players operating in the market.

List of Key Companies Covered in this Market Report:

  • 3M Company (NYSE: MMM)
  • Acrux Limited (OTCMKTS: ARUXF)
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co. Inc. (TYO: 4530)
  • Lavipharm S.A. (FRA: BXA0)
  • Luye Pharma Group (HKG: 2186)
  • Nutriband Inc. (NASDAQ: NTRB)
  • Viatris Inc. (NASDAQ: VTRS)


Transdermal Drug Delivery Systems Market Segmentation:

The report has segmented the global transdermal drug delivery systems market on the basis of technology, application and region.


Transdermal Drug Delivery Systems Market by Technology:

  • Electroporation
  • Radiofrequency
  • Iontophoresis
  • Microporation
  • Thermal
  • Mechanical Arrays
  • Ultrasound
  • Others


Transdermal Drug Delivery Systems Market by Application:

  • Central Nervous System
  • Pain Management
  • Cardiovascular
  • Hormone
  • Others


Geographical Analysis:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa


Explore Report Description with TOC & List of Figure:


Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape


If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.


Browse More Healthcare Industry Related Reports:

Digital Diabetes Management Market 2022-2027

Sleep Apnea Devices Market Report 2022-2027


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States

view more articles

About Article Author